Extracellular purines, purinergic receptors and tumor growth

F Di Virgilio, E Adinolfi - Oncogene, 2017 - nature.com
Virtually, all tumor cells as well as all immune cells express plasma membrane receptors for
extracellular nucleosides (adenosine) and nucleotides (ATP, ADP, UTP, UDP and sugar …

The P2X7 receptor in inflammatory diseases: angel or demon?

LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …

The P2X7 receptor: a main player in inflammation

E Adinolfi, AL Giuliani, E De Marchi, A Pegoraro… - Biochemical …, 2018 - Elsevier
Damage associated molecular patterns (DAMPs) are intracellular molecules released from
infected or injured cells to activate inflammatory and reparatory responses. One of the most …

CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury

LEB Savio, P de Andrade Mello, VR Figliuolo… - Journal of …, 2017 - Elsevier
Background & Aims The severity of sepsis can be linked to excessive inflammatory
responses resulting in hepatic injury. P2X7 receptor activation by extracellular ATP (eATP) …

A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) …

RK Farooq, A Tanti, S Ainouche, S Roger… - …, 2018 - Elsevier
A polymorphism in the P2RX7 gene that encodes for the P2X7 ionotropic ATP-gated
receptor (P2X7R) protein has been shown to be associated with an increased risk for …

P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses

E Orioli, E De Marchi, A Lisa Giuliani… - Current medicinal …, 2017 - ingentaconnect.com
P2X7 receptor is an ion channel activated by extracellular adenosine trisphosphate (eATP)
that attracted increasing attention for its role in immune reactions, neurobiology and …

Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL‐1β Pathway

J Zhou, G Tian, Y Quan, J Li, X Wang… - Oxidative medicine …, 2020 - Wiley Online Library
P2X7 purinergic receptor (P2X7R) has been implicated in several cardiovascular diseases.
However, whether it regulates cardiac fibrosis remains elusive. Herein, its involvement in the …

Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy

J Li, K Chen, S Li, J Feng, T Liu, F Wang… - Drug Design …, 2016 - Taylor & Francis
Liver fibrosis is a dynamic reversible pathological process in the development of chronic
liver disease to cirrhosis. However, the current treatments are not administered for a long …

The purinergic P2X7 receptor-NLRP3 inflammasome pathway: A new target in alcoholic liver disease?

B Le Daré, PJ Ferron, T Gicquel - International journal of molecular …, 2021 - mdpi.com
The World Health Organization has estimated that approximately 3 million deaths are
attributable to alcohol consumption each year. Alcohol consumption is notably associated …

[HTML][HTML] Transforming growth factor beta 1 drives a switch in connexin mediated cell-to-cell communication in tubular cells of the diabetic kidney

C Hills, GW Price, MJ Wall, TJ Kaufmann… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Changes in cell-to-cell communication have been linked to several
secondary complications of diabetes, but the mechanism by which connexins affect disease …